HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Health & Wellness Industry Roundup: July 11-15

This article was originally published in The Rose Sheet

Executive Summary

Compromise GMO legislation passes House; private equity looks for health, wellness investments, including China; and more news in brief.

You may also be interested in...

Nutritionals Mean Health Care To Reckitt And A Boon For China Business

Marketing Enfamil and other Mead Johnson nutritional and formula brands, says RB CEO Rakesh Kapoor, is "very much in the core of what consumer health stands for," and also immediately doubles the size of the firm's consumer business.

Church & Dwight's Gummy Plan: Health & Wellness Industry Roundup

Church & Dwight wants its Vitafusion adult line to rival its L’il Critters children's line growth; Omega Protein slumps while adjusting; Dupont boosts probiotic production; and more news in brief.

Walmart Cuts Verification Claim: Health And Wellness Industry Roundup

Sacco joins Prestige Brands as CFO another spiked supplement in international mali; and BIGR gains $55m funding.

Related Content


Related Companies




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts